1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. OPUS GENETICS INC.
Opus Genetics Inc.
XNAS: IRD
5.03 0.19 (3.93%)
1.2M
XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Opus Genetics Inc - IRD - stock price prediction, stock price target, analyst ratings from 12 analysts

Opus Genetics Inc has a share price target of US$ 10, revenue growth forecast of 22.7%, and profit growth estimate of 30.7% for FY25, based on top 12 analyst calls.